{
  "guideline": {
    "id": "PA166104985",
    "name": "Annotation of DPWG Guideline for rabeprazole and CYP2C19",
    "relatedChemicals": [
      {
        "id": "PA451216",
        "name": "rabeprazole",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA124",
        "name": "cytochrome P450 family 2 subfamily C member 19",
        "symbol": "CYP2C19"
      }
    ],
    "source": "DPWG",
    "recommendation": false,
    "guidelineGenes": [],
    "@id": "https://pharmgkb.org/guidelineAnnotation/PA166104985",
    "version": 23
  },
  "annotationGroups": [],
  "citations": [
    {
      "pmid": "21412232",
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2011
    }
  ]
}